FDA Targets Electronic Regulatory Submissions In Final Guidance
Executive Summary
The US agency’s new guidance doc lays bare the types of submissions device and drug makers should send to the agency electronically.
You may also be interested in...
New FDA Guidance Offers Additional Info On eStar Submissions
The US Food and Drug Administration says its guidance for manufacturers seeking premarket clearance is part of the agency’s overall commitment to improve e-submission consistency and enhance the review process.
New Guidance From FDA Lays Bare Types Of Submissions That Must Be Filed Electronically
A short, seven-page draft guidance from the US agency lists submissions that must be sent to the FDA in an electronic format.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?